R-Sibutramine, previously marketed under the brand name Meridia among others, is an appetite suppressant that is no longer widely recommended or prescribed due to safety concerns [1, 2]. Here's a breakdown of its characteristics:
How it Worked:
- Classified as a serotonin-norepinephrine reuptake inhibitor (SNRI) [1, 3]. SNRIs affect chemicals in the brain that influence appetite regulation.
- By increasing levels of serotonin, norepinephrine, and to a lesser extent dopamine, R-Sibutramine aimed to promote feelings of fullness and decrease hunger [2, 3].
Past Use:
- Until around 2010, R-Sibutramine was used as an adjunct (add-on therapy) for weight management, along with diet and exercise, in obese individuals with certain risk factors [2].
Why it's No Longer Recommended:
- Studies revealed an increased risk of serious side effects, including heart attack, stroke, and high blood pressure, particularly in people with pre-existing heart conditions or a history of stroke [1, 2].
- Due to these safety concerns, the manufacturers withdrew R-Sibutramine from the market, and regulatory bodies like the US Food and Drug Administration (FDA) no longer recommend its use [1].
Current Alternatives:
- Safer and more effective medications are available for weight management, and these should be discussed with a doctor to determine the best course of treatment for each individual [2].
Important to Note:
- If you were previously prescribed R-Sibutramine, consult your doctor about alternative weight management options.
- Do not take R-Sibutramine without consulting a healthcare professional, as it can be dangerous.